BIOLASE Reports Landmark Head-to-Head Study Published in Journal of Periodontology Concludes That BIOLASE REPAIR® Perio Protocol is Superior for Procedure Time and Patient-Reported Outcomes

OrthoNext Digital Platform for the JuniOrtho Plating System Receives FDA Clearance

“Together, OrthoNext and the JuniOrtho Plating System provide a complete solution for surgeons looking for a plating system to address the specific demands of advanced deformity and trauma reconstruction of the lower extremities in the pediatric population,” said Orthofix President of Global Orthopedics Paul Gonsalves.

SonarMed, New Pediatric Monitor Alerts Clinicians To Potential Airway Obstructions During Ventilation Launched

"The SonarMed airway monitoring device has revolutionized the way we care for our littlest patients. There is no other device in the world that can tell you where the endotracheal tube is located within the airway continuously in real-time, and whether the tube is obstructed or even partially occluded," said Jamie W. Powers, M.D., MBA, neonatologist at Huntington Hospital in Pasadena, California.

July 13, 2020

BIOLASE today announced data published in the Journal of Periodontology from a clinical trial conducted at The McGuire Institute. (The McGuire Institute is a not-for-profit organization with a unique vision for advancing the practice of dentistry through clinically-relevant research.)

BIOLASE reports, designed to meet the stringent American Association of Periodontology Best Evidence Consensus (BEC) standards, this first-of-its-kind study compared BIOLASE’s REPAIR® Perio protocol to the traditional Minimally Invasive Surgical Technique (MIST) treatment of moderate to severe generalized periodontitis.

The study found that the REPAIR Perio protocol had shorter procedure times than open flap procedures, as well as less bruising, swelling, and post-operative bleeding, demonstrating that REPAIR is as effective as open flap procedures in clinical parameters, such as pocket depth and attachment level, but with significantly better patient-reported outcomes.

“With 65 million Americans suffering from periodontitis, the findings from this study are significant in determining the best course of treatment for these patients,” said Todd Norbe, president and CEO of BIOLASE. “The study unequivocally confirms that patient-reported outcomes were significantly better after laser procedures. Using laser technology, periodontitis can now be treated – with less pain and greater patient acceptance – by both periodontists and general dentists alike. Studies continue to suggest that periodontal health is essential for overall health, as related to susceptibility to infection, including COVID-19 infections.”

BIOLASE believes this landmark study is the first controlled, multi-centered, blinded study on lasers in managing moderate to severe periodontitis. 54 patients were enrolled at five different sites, with six experienced periodontists.  It is also the only laser study in managing periodontitis designed to meet the stringent American Association of Periodontology BEC standards. To view the study results, visit here.

The REPAIR Perio protocol utilizes Waterlase® laser technology to provide safe, minimally invasive, effective laser treatment for periodontal disease.

 

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles